These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17894171)

  • 1. Race in a bottle. Drugmakers are eager to develop medicines targeted at ethnic groups, but so far they have made poor choices based on unsound science.
    Kahn J
    Sci Am; 2007 Aug; 297(2):40-5. PubMed ID: 17894171
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of hydralazine/isosorbide dinitrate in racial/ethnic subgroups with heart failure.
    Hammermeister KE; Fairclough D; Emsermann CB; Hamman R; Ho M; Phibbs S; Plomondon M; Valuck R; West D; Steiner JF
    Clin Ther; 2009 Mar; 31(3):632-43. PubMed ID: 19393854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fixed-dose isosorbide dinitrate-hydralazine: race-based cardiovascular medicine benefit or mirage?
    Ferdinand KC
    J Law Med Ethics; 2008; 36(3):458-63. PubMed ID: 18840236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of hydralazine-isosorbide dinitrate combination in African American and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction.
    Golwala HB; Thadani U; Liang L; Stavrakis S; Butler J; Yancy CW; Bhatt DL; Hernandez AF; Fonarow GC
    J Am Heart Assoc; 2013 Aug; 2(4):e000214. PubMed ID: 23966379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial commentary on fixed combination isosorbide dinitrate/hydralazine for nitric-oxide-enhancing therapy in heart failure.
    Flack JM
    Expert Opin Pharmacother; 2007 Feb; 8(3):275-7. PubMed ID: 17266462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethnic pharmacology: science, research, race, and market share.
    O'Malley P
    Clin Nurse Spec; 2005; 19(6):291-3. PubMed ID: 16294053
    [No Abstract]   [Full Text] [Related]  

  • 7. Fixed-Dose Versus Off-Label Combination of Isosorbide Dinitrate Plus Hydralazine Hydrochloride: Retrospective Propensity-Matched Analysis in Black Medicare Patients with Heart Failure.
    Ofili E; Anand I; Williams RA; Akinboboye O; Xu L; Puckrein G
    Adv Ther; 2017 Aug; 34(8):1976-1988. PubMed ID: 28707284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From disparity to difference: how race-specific medicines may undermine policies to address inequalities in health care.
    Kahn J
    South Calif Interdiscip Law J; 2005; 15(1):105-30. PubMed ID: 17333581
    [No Abstract]   [Full Text] [Related]  

  • 9. Isosorbide dinitrate-hydralazine improves outcomes in African Americans with heart failure.
    Colvin-Adams M; Taylor AL
    Cleve Clin J Med; 2007 Mar; 74(3):227-34. PubMed ID: 17375804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isosorbide dinitrate and hydralazine as therapy for African Americans with heart failure; a failed paradigm?
    Yancy CW; Feldman A
    Clin Transl Sci; 2009 Aug; 2(4):309-11. PubMed ID: 20443909
    [No Abstract]   [Full Text] [Related]  

  • 11. Race as a proxy for drug response: the dangers and challenges of ethnic drugs.
    Bowser R
    De Paul Law Rev; 2004; 53(3):1111-26. PubMed ID: 16211761
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of isosorbide dinitrate and hydralazine in African-Americans with heart failure 9 years after the African-American Heart Failure Trial.
    Ferdinand KC; Elkayam U; Mancini D; Ofili E; Piña I; Anand I; Feldman AM; McNamara D; Leggett C
    Am J Cardiol; 2014 Jul; 114(1):151-9. PubMed ID: 24846808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Race-based medicine and justice as recognition: exploring the phenomenon of BiDil.
    Yu JH; Goering S; Fullerton SM
    Camb Q Healthc Ethics; 2009; 18(1):57-67. PubMed ID: 19091146
    [No Abstract]   [Full Text] [Related]  

  • 14. The isosorbide-hydralazine story: is there a case for race-based cardiovascular medicine?
    Ferdinand KC
    J Clin Hypertens (Greenwich); 2006 Mar; 8(3):156-8. PubMed ID: 16522991
    [No Abstract]   [Full Text] [Related]  

  • 15. Isosorbide dinitrate and hydralazine hydrochloride: a review of efficacy and safety.
    Ferdinand KC
    Expert Rev Cardiovasc Ther; 2005 Nov; 3(6):993-1001. PubMed ID: 16292990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs tailored to race move a step closer to reality.
    Senior K
    Drug Discov Today; 2005 Aug; 10(16):1076-7. PubMed ID: 16182189
    [No Abstract]   [Full Text] [Related]  

  • 17. Postcards: race and medicine in the 21st century.
    Tutton R
    Br J Gen Pract; 2004 Sep; 54(506):716-7. PubMed ID: 15558866
    [No Abstract]   [Full Text] [Related]  

  • 18. Underuse of hydralazine and isosorbide dinitrate for heart failure in patients of African ancestry: a cross-European survey.
    Brewster LM
    ESC Heart Fail; 2019 Jun; 6(3):487-498. PubMed ID: 30892835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The paradox of race in the Bidil debate.
    Crawley L
    J Natl Med Assoc; 2007 Jul; 99(7):821-2. PubMed ID: 17668653
    [No Abstract]   [Full Text] [Related]  

  • 20. Bidil: recontextualizing the race debate.
    Séguin B; Hardy B; Singer PA; Daar AS
    Pharmacogenomics J; 2008 Jun; 8(3):169-73. PubMed ID: 18195727
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.